Kristen Sheppard | Senior Vice President of Investor Relations |
Doug Fambrough | Chief Executive Officer |
Doug Pagan | Chief Financial Officer |
Shreeram Aradhye | Chief Medical Officer |
Jonathan Miller | Evercore |
Mani Foroohar | SVB Leerink |
Luca Issi | RBC Capital |
Stephen Willey | Stifel |
Yigal Nochomovitz | Citigroup |
Brendan Smith | Cowen |
Thomas Yip | H. C. Wainwright |
Madhu Kumar | Goldman Sachs |
Yuan Zhi | B. Riley Securities |
Good morning, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals Third Quarter 2021 Financial Results Conference Call.
As a reminder, this conference call is being recorded at the company’s request. I will now turn the call over to your host, Kristen Sheppard, Senior Vice President of Investor Relations at Dicerna. Please go ahead.
Thank you, and welcome to Dicerna’s third quarter 2021 financial results and business highlights conference call.